PW Medtech Group Limited

HKSE 1358.HK

PW Medtech Group Limited EBIT Margin for the year ending December 31, 2023: 34.25%

PW Medtech Group Limited EBIT Margin is 34.25% for the year ending December 31, 2023, a 89.74% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • PW Medtech Group Limited EBIT Margin for the year ending December 31, 2022 was 18.05%, a 5.21% change year over year.
  • PW Medtech Group Limited EBIT Margin for the year ending December 31, 2021 was 17.16%, a 266.47% change year over year.
  • PW Medtech Group Limited EBIT Margin for the year ending December 31, 2020 was -10.31%, a -193.63% change year over year.
  • PW Medtech Group Limited EBIT Margin for the year ending December 31, 2019 was 11.01%, a -43.53% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
HKSE: 1358.HK

PW Medtech Group Limited

CEO Ms. Yue'e Zhang
IPO Date Nov. 8, 2013
Location China
Headquarters Building 1
Employees 1,302
Sector Health Care
Industries
Medical Instruments Pharmaceuticals Private Equity
Description

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Similar companies

1345.HK

China Pioneer Pharma Holdings Limited

USD 0.30

-0.02%

1349.HK

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

USD 0.29

2.68%

StockViz Staff

January 15, 2025

Any question? Send us an email